Discover
ENVB
Enveric Biosciences, Inc.
1.62
2 x 1.05
2 x 1.93
bid
ask
+
0.02
1.25%
2 @ 07:44 PM
1.61 -0.01 (0.62%)
| Ytd | -55.37% | |
| 1y | -78.57% |
1.52
day range
1.63
1.27
52 week range
10.80
| Open | 1.62 | Prev Close | 1.60 | Low | 1.52 | High | 1.63 | Mkt Cap | 7.25M |
| Vol | 158.57K | Avg Vol | 115.80K | EPS | -12.18 | P/E | N/A | Forward P/E | -0.22 |
| Beta | 0.47 | Short Ratio | 0.31 | Inst. Own | 7.06% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | 04-23 | Earning | 08-15 | 50-d Avg | 1.43 | 200-d Avg | 2.57 | 1yr Est | 8.32 |
| Income Statement | |||
| Operating Expenses | 3.03M | ||
| Research and Development Expense | 1.36M | ||
| Selling, General and Administrative Expense | 1.64M | ||
| Operating Income | -3.03M | ||
| Interest Expense | 292.00 | ||
| Net Income | -3.03M | ||
| Net Income Common Stock | -3.03M | ||
| Net Income Common Stock (USD) | -3.03M | ||
| Consolidated Income | -3.03M | ||
| Earnings per Basic Share | -0.76 | ||
| Earnings per Basic Share (USD) | -0.76 | ||
| Earnings per Diluted Share | -0.76 | ||
| Earning Before Interest & Taxes (EBIT) | -3.03M | ||
| Earning Before Interest & Taxes (USD) | -3.03M | ||
| Weighted Average Shares | 3.99M | ||
| Weighted Average Shares Diluted | 3.99M | ||
| Balance Sheet | |||
| Cash and Equivalents | 8.30M | ||
| Cash and Equivalents (USD) | 8.30M | ||
| Current Assets | 8.79M | ||
| Property, Plant & Equipment Net | 81.93K | ||
| Total Assets | 8.94M | ||
| Current Liabilities | 861.48K | ||
| Total Liabilities | 861.48K | ||
| Accumulated Retained Earnings (Deficit) | -119.51M | ||
| Accumulated Other Comprehensive Income | -594.68K | ||
| Shareholders Equity | 8.08M | ||
| Shareholders Equity (USD) | 8.08M | ||
| Assets Non-Current | 150.67K | ||
| Trade and Non-Trade Payables | 709.54K | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 36.83K | ||
| Net Cash Flow from Financing | 5.84M | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | 3.39M | ||
| Issuance (Purchase) of Equity Shares | 5.86M | ||
| Net Cash Flow from Operations | -2.44M | ||
| Effect of Exchange Rate Changes on Cash | -12.93K | ||
| Share Based Compensation | 125.11K | ||